Cynthia D O'Malley

Summary

Affiliation: Amgen Inc
Country: USA

Publications

  1. pmc Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease
    Robert I Griffiths
    Outcomes Insights, Inc, 340 North Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Med Res Methodol 13:32. 2013
  2. doi request reprint The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study
    Cynthia D O'Malley
    Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320, USA
    J Womens Health (Larchmt) 21:887-94. 2012
  3. doi request reprint Trends in dual-energy X-ray absorptiometry in the United States, 2000-2009
    Cynthia D O'Malley
    Center for Observational Research, Amgen, Inc, South San Francisco, CA 94080, USA
    J Clin Densitom 14:100-7. 2011
  4. doi request reprint Prevalence and incidence of comorbidities in elderly women with ovarian cancer
    Victoria M Chia
    Amgen Inc, Thousand Oaks, CA, USA Electronic address
    Gynecol Oncol 129:346-52. 2013

Detail Information

Publications4

  1. pmc Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease
    Robert I Griffiths
    Outcomes Insights, Inc, 340 North Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Med Res Methodol 13:32. 2013
    ..Using Medicare claims, we examined the impact of selecting shorter versus longer prevalence periods on the incidence and misclassification of 12 relatively common conditions in older persons...
  2. doi request reprint The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study
    Cynthia D O'Malley
    Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320, USA
    J Womens Health (Larchmt) 21:887-94. 2012
    ..We report on this disparity and add further evidence about the relationship among age, comorbidity, and survival after ovarian cancer...
  3. doi request reprint Trends in dual-energy X-ray absorptiometry in the United States, 2000-2009
    Cynthia D O'Malley
    Center for Observational Research, Amgen, Inc, South San Francisco, CA 94080, USA
    J Clin Densitom 14:100-7. 2011
    ..Continuing to provide access to DXA testing for women at increased risk of osteoporosis is important to providing high-quality care for metabolic bone disease in the United States...
  4. doi request reprint Prevalence and incidence of comorbidities in elderly women with ovarian cancer
    Victoria M Chia
    Amgen Inc, Thousand Oaks, CA, USA Electronic address
    Gynecol Oncol 129:346-52. 2013
    ..Studies suggest comorbidity plays an important role in ovarian cancer. We characterized the epidemiology of comorbid conditions in elderly U.S. women with ovarian cancer...